Acquisitions and Other Transactions (Jai Pharma Limited) (Narrative) (Details) $ in Millions			12 Months Ended
	Nov. 20, 2015 USD ($) shareholder		Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Business Acquisition [Line Items]
Goodwill			$ 9,231.9	$ 5,380.1	$ 4,049.3
Maximum
Business Acquisition [Line Items]
Rate used to discount net cash inflows to present values			9.80%
Minimum
Business Acquisition [Line Items]
Rate used to discount net cash inflows to present values			0.90%
Jai Pharma Limited
Business Acquisition [Line Items]
Acquisition purchase price	$ 750.0
Purchase consideration, contingent consideration, maximum	18.0
Net assets acquired	$ 711.1	[1]	$ 711.1
Minimum number of former shareholders providing services | shareholder	1
Number of shareholders | shareholder	2
Post-acquisition consulting services period	2 years
Working capital and other adjustments excluded	$ 7.0
Expected cost to complete				5.0
Identified intangible assets	437.0	[1]	437.0
Goodwill	$ 317.2	[1]	323.9
Amount of goodwill expected to be tax deductible			$ 150.0
Acquisition related costs				$ 8.5
Jai Pharma Limited | Product rights and licenses
Business Acquisition [Line Items]
Acquired intangible assets, weighted average useful life, in years	9 years
Jai Pharma Limited | Maximum
Business Acquisition [Line Items]
Purchase consideration, contingent consideration, maximum	$ 50.0
Rate used to discount net cash inflows to present values	11.00%
Jai Pharma Limited | Minimum
Business Acquisition [Line Items]
Rate used to discount net cash inflows to present values	10.00%

[1] As previously reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, as amended.